84-2172-20 [取扱停止]CDC20 (Cell Division Cycle Protein 20 Homolog, CDC20A, MGC102824, bA276H19.3, p55CDC) 50ul 210022

※お見積書はカートで印刷できます

冷凍

特徴

  • The cell division cycle demands accuracy to avoid the accumulation of genetic damage.
  • This process is controlled by molecular circuits called "checkpoints" that are common to all eukaryotic cells (1).
  • Checkpoints monitor DNA integrity and cell growth prior to replication and division at the G1/S and G2/M transitions, respectively.
  • The cdc2-cyclin B kinase is pivotal in regulating the G2/M transition (2,3).
  • Cdc2 is phosphorylated at Thr14 and Tyr15 during G2-phase by the kinases Wee1 and Myt1, rendering it inactive.
  • The tumor suppressor protein retinoblastoma (Rb) controls progression through the late G1 restriction point (R) and is a major regulator of the G1/S transition (4).
  • During early and mid G1-phase, Rb binds to and represses the transcription factor E2F (5).
  • The phosphorylation of Rb late in G1-phase by CDKs induces Rb to dissociate from E2F, permitting the transcription of S-phase-promoting genes.
  • In vitro, Rb can be phosphorylated at multiple sites by cdc2, cdk2, and cdk4/6 (6-8).
  • DNA damage triggers both the G2/M and the G1/S checkpoints.
  • DNA damage activates the DNA-PK/ATM/ATR kinases, which phosphorylate Chk at Ser345 (9), Chk2 at Thr68 (10) and p53 (11).
  • The Chk kinases inactivate cdc25 via phosphorylation at Ser216, blocking the activation of cdc2.CDC20 binds to and activates the anaphase-promoting complex (APC) during mitosis and G1 phase of the cell cycle (12).
  • Moreover, CDC20 is necessary for ubiquitin ligase activity of the APC/cyclosome (APC/C).
  • In metaphase MAD2L1 inactivates the CDC20-APC/C complex, while in anaphase this inhibition is lost and CDC20-APC/C degrades its substrates (13).
  • p53 and p21 suppress expression of CDC20 upon genotoxic stresses and ectopic introduction of p53.
  • siRNA mediated knock-down of CDC20 in cancer cells leads to attenuated cell growth and induces G(2)/M arrest, suggesting that CDC20 is a possible therapeutic target of cancer (14).
  • Organization of neuronal circuits requires presynaptic axonal differentiation and synapse formation.
  • CDC20-APC regulates presynaptic differentiation in postmitotic neurons by triggering the required degradation of the transcription factor NeuroD2 (15)
  • Applications:Suitable for use in Immunofluorescence and Western Blot.
  • Other applications not tested.
  • Recommended Dilution:Western Blot: 1:500-1:2000Immunofluorescence: 1:50-1:200Optimal dilutions to be determined by the researcher.
  • Storage and Stability:May be stored at 4°C for short-term only.
  • Aliquot to avoid repeated freezing and thawing.
  • Store at -20°C.
  • Aliquots are stable for 12 months after receipt.
  • For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

仕様

  • Size:50ul
  • Host:rabbit
  • Source Antibody:human
  • Grade:Affinity Purified
  • Purity:Purified by affinity chromatography.
  • Form:Supplied as a liquid in PBS, pH 7.3, 0.02% sodium azide, 50% glycerol.
  • Specificity:Recognizes CDC20. Species Crossreactivity: human, mouse, rat
  • Isotype:IgG
  • Calc Applications Abbrev:IF WB
  • Calc Crossreactivity:Hu Mo Rt
  • Immunogen:Recombinant protein corresponding to human CDC20.
  • Shelf Life:1year
  • Swiss Prot Number:Q12834
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-2172-20
型番
210022
入り数
1個
標準価格
108,000円(税抜)
WEB価格
取扱停止
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る